Trial intelligence / Profile preview

Tanreqing Injection randomized controlled trial in dengue fever

ChiCTR-IPR-15006778Phase 4Not yet recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Jul 2015
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tanreqing in dengue fever (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Duration of fever and White blood cell count. Planned start Jul 2015; status: not yet recruiting.

02

Drugs

tanreqing
03

Conditions

dengue fever

Beyond the preview

Go deeper on ChiCTR-IPR-15006778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15006778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call